☆ 4.7 Review

Clinical Manifestations and Surgical Management of Breast Implant-Associated Anaplastic Large Cell Lymphoma: Beyond the NCCN Guidelines

ANNALS OF SURGICAL ONCOLOGY (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Surgery

Breast Implant-associated Anaplastic Large Cell Lymphoma A Prospective Series of 52 Patients

Sarah E. Tevis et al.

Summary: This study evaluated breast implant ALCL patients in a prospective manner and reported their presentation, clinical course, treatment, and outcomes. The majority of patients presented with delayed seroma and most had Stage IA disease. Patient outcomes were excellent with a low recurrence rate and high complete remission rate.

ANNALS OF SURGERY (2022)

添加到收藏夹

Review Oncology

Current Progress in Breast Implant-Associated Anaplastic Large Cell Lymphoma

Yichen Wang et al.

Summary: This article provides a review on the etiology, pathogenesis, diagnosis, and therapy of breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL). It also reviews the physical characteristics of breast implants and their potential pathogenic effect, aiming to provide a foundation for the optimal choice of implants with minimal morbidity.

FRONTIERS IN ONCOLOGY (2022)

添加到收藏夹

Review Oncology

Breast Implant-associated Anaplastic Large Cell Lymphoma

Shaikha Alotaibi et al.

Summary: BIA-ALCL is a rare lymphoproliferative disorder associated with textured implants, with unclear pathogenesis requiring further research. Proper evaluation for diagnosis confirmation is necessary, and treatment approaches vary depending on the disease severity.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2021)

添加到收藏夹

Article Pathology

Breast implant-associated anaplastic large cell lymphoma: clinical follow-up and analysis of sequential pathologic specimens of untreated patients shows persistent or progressive disease

Mark G. Evans et al.

Summary: This study analyzed sequential pathologic specimens from patients with breast implant-associated ALCL, revealing that these neoplasms persist or progress over time if not treated with standard-of-care therapy.

MODERN PATHOLOGY (2021)

添加到收藏夹

Review Oncology

Breast implant-associated anaplastic large cell lymphoma: A comprehensive review

Antonio Marra et al.

CANCER TREATMENT REVIEWS (2020)

添加到收藏夹

Article Surgery

Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured breast implants

Peter G. Cordeiro et al.

JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY (2020)

添加到收藏夹

Article Surgery

Characteristics and Treatment of Advanced Breast Implant-Associated Anaplastic Large Cell Lymphoma

Meredith S. Collins et al.

PLASTIC AND RECONSTRUCTIVE SURGERY (2019)

添加到收藏夹

Article Surgery

Patient Registry and Outcomes for Breast Implants and Anaplastic Large Cell Lymphoma Etiology and Epidemiology (PROFILE): Initial Report of Findings, 2012-2018

Colleen M. McCarthy et al.

PLASTIC AND RECONSTRUCTIVE SURGERY (2019)

添加到收藏夹

Article Surgery

Breast Reconstruction Following Breast Implant-Associated Anaplastic Large Cell Lymphoma

Gregory A. Lamaris et al.

PLASTIC AND RECONSTRUCTIVE SURGERY (2019)

添加到收藏夹

Article Medicine, General & Internal

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

Steven Horwitz et al.

LANCET (2019)

添加到收藏夹

Article Pathology

Clinicopathologic Features and Prognostic Impact of Lymph Node Involvement in Patients With Breast Implant-associated Anaplastic Large Cell Lymphoma

Maria C. Ferrufino-Schmidt et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2018)

添加到收藏夹

Article Surgery

NCCN Consensus Guidelines for the Diagnosis and Management of Breast Implant-Associated Anaplastic Large Cell Lymphoma

Mark W. Clemens et al.

AESTHETIC SURGERY JOURNAL (2017)

添加到收藏夹

Review Surgery

Breast Implant-Associated Anaplastic Large Cell Lymphoma A Systematic Review

Ashley N. Leberfinger et al.

JAMA SURGERY (2017)

添加到收藏夹

Article Oncology

Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant-Associated Anaplastic Large-Cell Lymphoma

Mark W. Clemens et al.

JOURNAL OF CLINICAL ONCOLOGY (2016)

添加到收藏夹

Article Dermatology

Skin involvement as the first manifestation of breast implant-associated anaplastic large cell lymphoma

Rebeca Alcala et al.

JOURNAL OF CUTANEOUS PATHOLOGY (2016)

添加到收藏夹

Article Oncology

Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II Study

Barbara Pro et al.

JOURNAL OF CLINICAL ONCOLOGY (2012)

添加到收藏夹

Review Surgery

Anaplastic Large Cell Lymphoma and Breast Implants: A Systematic Review

Benjamin Kim et al.

PLASTIC AND RECONSTRUCTIVE SURGERY (2011)

添加到收藏夹

Article Medicine, General & Internal

Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas.

Anas Younes et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.